320 related articles for article (PubMed ID: 17129691)
1. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
2. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
Salameh AK; Taylor LS
J Pharm Sci; 2006 Feb; 95(2):446-61. PubMed ID: 16380975
[TBL] [Abstract][Full Text] [Related]
3. Determination of hydrate transition temperature using transformation kinetics obtained by Raman spectroscopy.
Wikström H; Kakidas C; Taylor LS
J Pharm Biomed Anal; 2009 Feb; 49(2):247-52. PubMed ID: 19112003
[TBL] [Abstract][Full Text] [Related]
4. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
Amado AM; Nolasco MM; Ribeiro-Claro PJ
J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
[TBL] [Abstract][Full Text] [Related]
5. Hyphenated spectroscopy as a polymorph screening tool.
Aaltonen J; Strachan CJ; Pöllänen K; Yliruusi J; Rantanen J
J Pharm Biomed Anal; 2007 Jun; 44(2):477-83. PubMed ID: 17367979
[TBL] [Abstract][Full Text] [Related]
6. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
8. Solubility and stability of anhydrate/hydrate in solvent mixtures.
Qu H; Louhi-Kultanen M; Kallas J
Int J Pharm; 2006 Sep; 321(1-2):101-7. PubMed ID: 16784825
[TBL] [Abstract][Full Text] [Related]
9. Investigating dehydration from compacts using terahertz pulsed, Raman, and near-infrared spectroscopy.
Kogermann K; Zeitler JA; Rantanen J; Rades T; Taday PF; Pepper M; Heinämäki J; Strachan CJ
Appl Spectrosc; 2007 Dec; 61(12):1265-74. PubMed ID: 18198016
[TBL] [Abstract][Full Text] [Related]
10. Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
Aaltonen J; Gordon KC; Strachan CJ; Rades T
Int J Pharm; 2008 Dec; 364(2):159-69. PubMed ID: 18555625
[TBL] [Abstract][Full Text] [Related]
11. Terahertz pulsed spectroscopy and imaging in the pharmaceutical setting--a review.
Zeitler JA; Taday PF; Newnham DA; Pepper M; Gordon KC; Rades T
J Pharm Pharmacol; 2007 Feb; 59(2):209-23. PubMed ID: 17270075
[TBL] [Abstract][Full Text] [Related]
12. Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling.
Kogermann K; Aaltonen J; Strachan CJ; Pöllänen K; Veski P; Heinämäki J; Yliruusi J; Rantanen J
J Pharm Sci; 2007 Jul; 96(7):1802-20. PubMed ID: 17253647
[TBL] [Abstract][Full Text] [Related]
13. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
Karki S; Friscić T; Jones W; Motherwell WD
Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
[TBL] [Abstract][Full Text] [Related]
14. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
Zhang GG; Law D; Schmitt EA; Qiu Y
Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
[TBL] [Abstract][Full Text] [Related]
15. The use of dynamic vapour sorption and near infra-red spectroscopy (DVS-NIR) to study the crystal transitions of theophylline and the report of a new solid-state transition.
Vora KL; Buckton G; Clapham D
Eur J Pharm Sci; 2004 Jun; 22(2-3):97-105. PubMed ID: 15158895
[TBL] [Abstract][Full Text] [Related]
16. Role of excipients in hydrate formation kinetics of theophylline in wet masses studied by near-infrared spectroscopy.
Jørgensen AC; Airaksinen S; Karjalainen M; Luukkonen P; Rantanen J; Yliruusi J
Eur J Pharm Sci; 2004 Sep; 23(1):99-104. PubMed ID: 15324927
[TBL] [Abstract][Full Text] [Related]
17. Applications of process analytical technology to crystallization processes.
Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
[TBL] [Abstract][Full Text] [Related]
18. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the Isothermal Dehydration of Crystalline Hydrates Using Low-Frequency Raman Spectroscopy.
Robert C; Fraser-Miller SJ; Be Rziņš KR; Okeyo PO; Rantanen J; Rades T; Gordon KC
Mol Pharm; 2021 Mar; 18(3):1264-1276. PubMed ID: 33406363
[TBL] [Abstract][Full Text] [Related]
20. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
Kogermann K; Veski P; Rantanen J; Naelapää K
Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
